GT Biopharma Inc. (GTBP)

NASDAQ

$5.43

$-1.88

(-25.65%)

Previous Close: ⁦$7.31⁩

Market Closed

GT Biopharma Inc. (GTBP) Live Price Chart

Last updated: ⁦2026-10-22 07:11:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

GT Biopharma Inc. (GTBP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.43, with a market capitalization of $13.19M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.91 to $28.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13.19M
Open	$6.81
Day's High	$14,799.83
Day's Low	$4.91
Previous Close	$7.31
Volume	167.50K
Average Volume	59.34K
P/E Ratio	--
52-Week High	$28.75
52-Week Low	$4.91
Dividend Yield	2.35%
Earnings Date	--

GT Biopharma Inc. (GTBP) Latest Closing Stock Price

GT Biopharma Inc. (GTBP) last closed at $7.31 as of 2026-10-21 23:31:00, unchanged from the previous close of $7.31.

During the latest regular trading session, GTBP traded between $4.91 and $14,799.83, with a volume of 167.50K shares. The closing price was near the lower end and near the lower end of its 52-week range.

GT Biopharma Inc. (GTBP) 7-Day Stock Price Change

Over the past seven days, GT Biopharma Inc. (GTBP) moved from $6.50 to $5.43, representing a decline of 16.46% ($1.07).

The stock traded between $5.31 and $7.50 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 62.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

GTBP 52-Week Price Position

Position in Range: 2.2%

52W Low$4.91

52W High$28.75

GTBP is currently trading at $5.43, placing it 2.2% of the way from its 52-week low of $4.91 to its 52-week high of $28.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is GT Biopharma Inc. (GTBP)?

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

GT Biopharma Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1
Exchange	NASDAQ
Company Website	https://www.gtbiopharma.com

How to Buy GT Biopharma Inc. (GTBP) Stock on MEXC

Eligible investors can buy real shares of GT Biopharma Inc. (GTBP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GTBP and Place Your Order

Open the RealStocks trading page and search for GTBP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is GT Biopharma Inc. (GTBP) stock price today?

GT Biopharma Inc. (GTBP) is currently trading at $ 5.43, down 25.72% ($1.88) from the previous close of $ 7.31. Intraday prices update in real time during regular trading hours.

2.Is GTBP stock going up or down today?

As of 2026-10-21 23:31:00, GTBP is trading at $ 5.43, down 25.72% ($1.88) from its previous close of $ 7.31. The stock has traded between $ 4.91 and $ 14,799.83 during today’s regular session. Past price movements do not guarantee future results.

3.What is GTBP pre-market price?

As of 2026-10-21 23:31:00, GTBP is trading at $ 7.10 in pre-market trading, down 2.94% ($0.21) from the previous close of $ 7.31. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GTBP after-hours price?

As of 2026-10-21 23:31:00, GTBP is trading at $ 5.39 in after-hours trading, down 26.27% ($1.92) from the regular-session close of $ 7.31. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GTBP stock trading now?

GTBP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GTBP sit relative to its 52-week high and low?

Over the past 52 weeks, GTBP has traded between a low of $ 4.91 and a high of $ 28.75. At $ 5.43, the stock is positioned 2.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is GT Biopharma Inc. in?

GT Biopharma Inc. (GTBP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is GT Biopharma Inc.'s market capitalization and where is it listed?

GT Biopharma Inc. is listed on the NASDAQ exchange with a market capitalization of $ 13.19M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GTBP valued in terms of P/E ratio and EPS?

GTBP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -18.16. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does GT Biopharma Inc. pay a dividend?

GT Biopharma Inc. pays an indicated annual cash dividend of $ 0.13 per share, with a current dividend yield of 2.35% based on the latest share price. Dividend policies are subject to change at the board's discretion.